Salbutamol: A Drug Study On
Salbutamol: A Drug Study On
Salbutamol: A Drug Study On
SALBUTAMOL
Submitted to:
Submitted by:
BRAND NAME:
Proventil, Vospira ER, Accuneb, Ventodisk, Ventolin
PREGNANCY CATERGORY: C
USES: Treatment or prevention of bronchospasm due to reversible obstructive airway disease, prevention of exercise-
induced bronchospasm.
INDICATION
To prevent exercise-induced bronchospasm and to treat or prevent bronchospasms in patient with reversible
obstructive airway disease or acute bronchospatic attack.
CONTRAINDICATIONS
Cautions: Hypertension, cardiovascular disease, hyperthyroidism, diabetes, HF, convulsive disorders, glaucoma,
hypokalemia, arrhythmias.
CLASSIFICATION
CLINICAL: Bronchodilator.
3 – 4 times/day
ELDERLY: 2 mg
4 times/day
Maximum: 8 mg
3 – 4 times/day
CHILDREN 6–12 YRS: 2 mg Per day
Maximum: 24 mg
Exercise-Induced Bronchospasm
No Dose Adjustment
MODE OF ACTION
Stimulates beta2 -adrenergic receptors in lungs, resulting in relaxation of bronchial smooth muscle. Therapeutic Effect:
Relieves bronchospasm and reduces airway resistance.
SIDE EFFECTS
Headache, restlessness, Insomnia, asthenia, altered taste. Drowsiness, diarrhea, dry mouth,
nervousness, tremors, nausea, flushing, diaphoresis, anorexia.
dizziness, throat dryness and irritation, Inhalation: Dry, irritated mouth or
pharyngitis, B/P changes including throat; cough, bronchial irritation.
hypertension, heartburn, transient
wheezing.
Excessive sympathomimetic stimulation may produce palpitations, ectopy, tachycardia, chest pain, slight increase in
B/P followed by substantial decrease, chills, diaphoresis, blanching of skin.
Too-frequent or excessive use may lead to decreased bronchodilating effectiveness and severe, paradoxical
bronchoconstriction.
DRUG INTERACTION
LAB VALUES - May increase blood glucose level. May decrease serum
potassium level.
NURSING RESPONSIBILITIES
BASELINE ASSESSMENT
INTERVENTION/EVALUATION
PATIENT/FAMILY TEACHING
Kizior, R. J. (2019). Saunders Nursing Drug Handbook 2019. St. Louis: Elsevier. 233-237.
Nurse’s Drug Handbook. (2018). 17th edn. USA: Jones & Bartlett Learning.